retatrutide approval date eli lilly release Eli Lilly's retatrutide is still in clinical trials. But gym bros Retatrutide – new weight loss

Jastreboff and colleagues (NEJM, 2023) reported substantial body-weight reduction in obesity research populations, and Rosenstock and colleagues (Lancet, 2023) documented glycemic and weight effects in type-2 diabetes research populations

When rheumatologists use them for inflammatory arthritis, it is considered off-label prescribing a legal and common practice when supported by emerging clinical evidence and individualized patient need

Geoff Meacham, Bank of America's lead biotech and pharmaceuticals analyst, said in a client note in March that he expects 15% of US adults to be taking weight-loss drugs by 2035, up from 1% currently

PlexusDx provides personalized GLP-1 protocols designed to support your weight loss journey for as long as you need them

The same study found that people with a higher body mass index lost more weight after a year

A 2019 review in *Obstetrics & Gynecology* noted that any medication significantly slowing GI transit warrants contraceptive counseling, particularly for women using lower-dose formulations